Dynasil Corporation of America (NASDAQ:DYSL) Traded 5.2% Above Its 50 Day Moving Average


It is trading at $1.41 which is just a bit higher than $1.34, the 50 day moving average and which is well above the 200 day moving average of $1.28. The 50 day moving average went up $0.07 or +5.43% and the 200 day average went up $0.13 or +10.49%. Dynasil Corporation of America shares had a trading volume of 807 by the end of trading on Tuesday. Shares saw a steep decrease in trading volume of 95.67% under the normal average daily volume.

Investors are a little more bullish on shares of the company if you take into consideration the fall in short interest. The firm recorded a fall in short interest of -67.26% as of September 29, 2017 from the last reporting period. Short shares decreased 30,593 over that period. Days to cover increased 3.0 to 4.0 and the percentage of shorted shares was 0.00% on September 29.

The following firms have recently changed their position in DYSL. As of the end of the quarter Essex Investment Management Co LLC had bought a total of 29,535 shares growing its position 36.6%. The value in dollars went from $102,000 to $136,000 a change of 33.3% for the reporting period. As of quarter end Dowling & Yahnke LLC had acquired 4,960 shares growing its stake by 3.6%. The value of the total investment in Dynasil Corporation of America increased from $172,000 to $174,000 a change of $2,000 quarter to quarter.

Blackrock Inc. added to its holdings by buying 1,016 shares an increase of 20.0% from 03/31/2017 to 06/30/2017. Blackrock Inc. currently owns 6,107 shares valued at $8,000. The value of the position overall is up by 33.3%. Finemark National Bank & Trust expanded its investment by buying 10,000 shares an increase of 0.7% in the quarter. Finemark National Bank & Trust now controls 1,347,591 shares worth $1,658,000. The total value of its holdings decreased 1.6%.

The P/E ratio is currently 8.29 and the market cap is 24.06M.

Dynasil Corporation of America, launched on February 11, 2008, is involved in the development, marketing and manufacturing of detection, sensing and analysis technology and optical components, as well as contract research. The Business’s products and services are used in a range of application markets, including the homeland security, industrial and medical markets sectors. The Company operates through three segments: Contract Research, Optics and Biomedical. The Contract Research segment consists of the Radiation Monitoring Devices, Inc. (RMD) business unit. The Optics segment operates through four business units: Dynasil Fused Silica, Optometrics Corporation (Optometrics), Hilger Crystals, Ltd (Hilger) and Evaporated Metal Films Corporation (EMF), which manufactures commercial products. The Biomedical segment consists of a business unit, Dynasil Biomedical Corporation (Dynasil Biomedical), a medical technology incubator, which owns rights to certain early-stage medical technologies..